ETF Managers Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $157K | Sell |
51,963
-588,010
| -92% | -$1.78M | 0.01% | 603 |
|
|
2022
Q4 | $1.49M | Buy |
639,973
+595,723
| +1,346% | +$1.39M | 0.07% | 123 |
|
|
2022
Q3 | $85K | Sell |
44,250
-2,738
| -6% | -$5.26K | ﹤0.01% | 654 |
|
|
2022
Q2 | $127K | Buy |
46,988
+5,957
| +15% | +$16.1K | ﹤0.01% | 674 |
|
|
2022
Q1 | $122K | Buy |
41,031
+97
| +0.2% | +$288 | ﹤0.01% | 623 |
|
|
2021
Q4 | $159K | Buy |
40,934
+4,727
| +13% | +$18.4K | ﹤0.01% | 620 |
|
|
2021
Q3 | $155K | Buy |
36,207
+7,756
| +27% | +$33.2K | ﹤0.01% | 621 |
|
|
2021
Q2 | $90K | Buy |
28,451
+2,442
| +9% | +$7.73K | ﹤0.01% | 626 |
|
|
2021
Q1 | $82K | Sell |
26,009
-15,290
| -37% | -$48.2K | ﹤0.01% | 646 |
|
|
2020
Q4 | $154K | Sell |
41,299
-4,074
| -9% | -$15.2K | ﹤0.01% | 583 |
|
|
2020
Q3 | $144K | Buy |
45,373
+24,853
| +121% | +$78.9K | ﹤0.01% | 592 |
|
|
2020
Q2 | $39K | Buy |
+20,520
| New | +$39K | ﹤0.01% | 594 |
|